Myocardial Infarction News and Research

RSS

Study shows the safety of COVID-19 vaccines for patients with cardiovascular disease

COVID-19 vaccination is not associated with an increased risk of heart attack or stroke in patients with established cardiovascular disease, according to a large study published today in Cardiovascular Research, a journal of the European Society of Cardiology.

23 Jun 2022

Math model predicts several useful new drug combinations that may help treat heart attacks

Researchers used mice to develop a mathematical model of a myocardial infarction, popularly known as a heart attack.

17 Jun 2022

First-of-its-kind technology repairs and regenerates heart muscle cells

Researchers at the University of Houston are reporting a first-of-its-kind technology that not only repairs heart muscle cells in mice but also regenerates them following a heart attack, or myocardial infarction as its medically known.

16 Jun 2022

Study shows alarming trends in mortality from alcoholic cirrhosis in the U.S.

Alcoholic cirrhosis is an advanced form of alcohol-related liver disease. In the United States between 2010 and 2016, alcohol-related liver disease was the primary cause of nearly 1 in 3 liver transplants, surpassing hepatitis C.

14 Jun 2022

Discovery could lead to a simple screening process for predicting heart attack risk

Combining information about the pattern of blood vessels in the retina with genetic data can enable accurate prediction of an individual's risk of coronary artery disease (CAD) and its potentially fatal outcome, myocardial infarction (MI), commonly known as a heart attack.

13 Jun 2022

Newer class of antidiabetic drugs reduced risk of hospitalization for heart failure

In cardiovascular outcome trials among adults with type 2 diabetes (T2D), sodium-glucose co-transporter 2 inhibitors (SGLT-2i) have shown therapeutic promise, including reduced risk of hospitalization for heart failure compared to placebo.

1 Jun 2022

Adults with primary glomerular disease have high cardiovascular risk, study shows

Among almost 2,000 adults with primary glomerular disease followed for a median of 6.8 years, risk of cardiovascular events including coronary artery, cerebrovascular, and peripheral vascular events, and death due to myocardial infarction or stroke was 2.5-fold higher compared to the general population.

1 Jun 2022

Study evaluates diagnostic performance of two blood-based biomarkers specific to Alzheimer's disease

A simple blood test to diagnose Alzheimer's disease, perhaps even years before symptoms appear, is an exciting possibility, but a new study shows that much more research is needed before these blood tests are routinely used in the clinical diagnostic setting.

26 May 2022

Reduced exercise capacity is common in long COVID patients

In a recent study posted to the medRxiv* preprint server, researchers illustrated cardiac findings in coronavirus disease 2019 (COVID-19)-recovered individuals more than a year after infection.

22 May 2022

Kyunurenic acid in cardiovascular therapy

In a recent study posted to the bioRxiv* preprint server, researchers assessed the impact of kynurenic acid on ischemic damage to the heart.

19 May 2022

Incidence of arterial and venous thromboembolism and death in COVID-19 patients

Researchers estimated the incidence of arterial or venous thrombosis in patients with coronavirus disease 2019.

19 May 2022

Analysis finds baffling variations in the treatment for heart attack patients in high-income nations

The best way to treat acute myocardial infarctions, commonly known as heart attacks, has been long established by international consensus. The types of treatments and recommended procedures are well-defined, widely known, and readily available in modern hospitals.

12 May 2022

Hypertensive disorders of pregnancy linked to CVD risk later in life

In a recent study published in the Journal of American College of Cardiology, researchers evaluated the associations between hypertensive disorders of pregnancy (HDP) and long-term cardiovascular disease (CVD).

12 May 2022

Single-cell RNA sequencing reveals characteristics of myeloid immune cells in coronary plaque

Through single-cell RNA sequencing, a research group has successfully illuminated the characteristics of Myeloid immune cells in coronary plaque, which causes acute coronary syndrome (this term includes conditions such as unstable angina and acute myocardial infarction (heart attack)).

6 May 2022

Free SARS-CoV-2 spike protein fragments may trigger platelet activation and clot formation in COVID-19

In a recent study under review in the Nature Portfolio journal and currently available on the Research Square* preprint server, researchers investigated the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (SP) in the thrombi (or blood clots).

5 May 2022

Study evaluates the associations between predisposing risk factors and heart attack in young women

A new Yale-led study has for the first time identified which risk factors are more likely to trigger a heart attack or acute myocardial infarction (AMI) for men and women 55 years and younger.

4 May 2022

Study reveals trends in clinical characteristics and outcomes of STEMI patients with COVID-19

A newly published analysis in the Journal of the American College of Cardiology1 of hospitalized patients with both a severe type of heart attack called STEMI (ST-elevation myocardial infarction) and coronavirus disease-19 (COVID-19) infection compares clinical outcomes for these patients during the first and second years of the COVID-19 pandemic.

3 May 2022

Myocardial Infarction News and Research

Study shows the safety of COVID-19 vaccines for patients with cardiovascular disease

Math model predicts several useful new drug combinations that may help treat heart attacks

First-of-its-kind technology repairs and regenerates heart muscle cells

Study shows alarming trends in mortality from alcoholic cirrhosis in the U.S.

Discovery could lead to a simple screening process for predicting heart attack risk

Newer class of antidiabetic drugs reduced risk of hospitalization for heart failure

Adults with primary glomerular disease have high cardiovascular risk, study shows

Study evaluates diagnostic performance of two blood-based biomarkers specific to Alzheimer's disease

Reduced exercise capacity is common in long COVID patients

Kyunurenic acid in cardiovascular therapy

Incidence of arterial and venous thromboembolism and death in COVID-19 patients

Analysis finds baffling variations in the treatment for heart attack patients in high-income nations

Hypertensive disorders of pregnancy linked to CVD risk later in life

Single-cell RNA sequencing reveals characteristics of myeloid immune cells in coronary plaque

Free SARS-CoV-2 spike protein fragments may trigger platelet activation and clot formation in COVID-19

Study evaluates the associations between predisposing risk factors and heart attack in young women

Study reveals trends in clinical characteristics and outcomes of STEMI patients with COVID-19

Study investigates intestinal ischemia in COVID-19 patients

Low dose aspirin is downgraded for preventing cardiovascular disease

Monoclonal-antibody combination AZD7442 prevents COVID-19

Snapping at new biotech breakthroughs with Gator Pro

Realizing the Importance of Medical Electronic Devices

Everything about SpatialOMx

Latest News

Life Science Microscopy eBook